Surgery Partners (SGRY) Projected to Post Earnings on Monday

Surgery Partners (NASDAQ:SGRY) will likely be issuing its Q3 2026 results before the market opens on Monday, November 9th. Analysts expect the company to post earnings of $0.1106 per share and revenue of $820.96 million for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Monday, November 9, 2026 at 8:30 AM ET.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.04. The business had revenue of $848.90 million for the quarter, compared to analyst estimates of $830.03 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter last year, the business posted $0.17 EPS. On average, analysts expect Surgery Partners to post $0.25 EPS for the current fiscal year and $0.26 EPS for the next fiscal year.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $23.21 on Monday. The company has a market cap of $3.04 billion, a P/E ratio of -33.16 and a beta of 1.90. Surgery Partners has a fifty-two week low of $11.41 and a fifty-two week high of $23.37. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95. The stock has a 50 day simple moving average of $15.13 and a two-hundred day simple moving average of $14.64.

Analysts Set New Price Targets

SGRY has been the topic of several recent research reports. Raymond James Financial set a $23.50 price target on Surgery Partners in a research note on Monday, October 26th. Zacks Research downgraded Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Monday, August 10th. Royal Bank Of Canada lowered shares of Surgery Partners from a “moderate buy” rating to a “hold” rating and set a $23.50 price target on the stock. in a research note on Monday, October 26th. TD Cowen reaffirmed a “buy” rating and set a $19.00 price objective on shares of Surgery Partners in a report on Friday, September 18th. Finally, Cantor Fitzgerald lowered shares of Surgery Partners from an “overweight” rating to a “hold” rating in a report on Monday, October 26th. Four investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $20.14.

Insider Transactions at Surgery Partners

In other news, Director Teresa DeLuca acquired 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were bought at an average price of $14.35 per share, with a total value of $143,500.00. Following the acquisition, the director directly owned 66,843 shares in the company, valued at $959,197.05. The trade was a 17.59% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 2.00% of the stock is owned by company insiders.

Surgery Partners Company Profile

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.